The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma.

Medical Oncology
Antonio Romo de Vivar ChavezMichael T Lotze

Abstract

Renal cell carcinoma (RCC) is the eighth most common malignancy in adults in the United States. More than 50% of individuals present with metastatic disease and conventional chemotherapeutic strategies have been associated with poor response rates. Immunotherapy with Interleukin (IL)-2, however, induces durable remission, achieving >10 year recurrence free survival in 5-10% of patients with advanced RCC. First described as a T cell growth factor, IL-2 has a wide spectrum of effects in the immune system. Some of the possible mechanisms by which IL-2 carries out its anticancer effects include the augmentation of cytotoxic immune cell functions and reversal of T cell anergy, enabling delivery of immune cells and possibly serum components into tumor. IL-2 indirectly limits tumor escape mechanisms such as defective tumor cell expression of Class I or Class II molecules or expansion of regulatory T cells. Indirect effects on the tumor microenvironment are also likely and associated with rather dramatic T cell infiltration during the global delayed type hypersensitivity response that is associated with systemic IL-2 administration. The IL-2 signaling pathway, its effects on immune cells, and its role in various independent mechanisms ...Continue Reading

References

Mar 1, 1977·The Journal of Urology·J E MontieD K Montague
Aug 1, 1978·The Journal of Urology·J B DekernionR B Smith
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S D FossåR Sylvester
May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A NeidhartR L Tuttle
Apr 5, 1990·The New England Journal of Medicine·M S KlempnerM B Atkins
Apr 1, 1986·Urology·M GolimbuP Morales
May 1, 1997·European Journal of Immunology·T De SmedtM Moser
Jun 10, 1998·The Journal of Experimental Medicine·W F DavidsonT N Fredrickson
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·G S Salvesen, V M Dixit
Oct 6, 1999·The Journal of Experimental Medicine·J P MedemaR Offringa
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J MotzerM Mazumdar
Sep 19, 2001·The Journal of Clinical Investigation·A D WellsL A Turka
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S M TahirM A Exley
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerMadhu Mazumdar
Mar 22, 2002·Nature Reviews. Cancer·P Hersey, X D Zhang
May 10, 2002·Journal of Immunotherapy·Paul Andrew Antony, Nicholas P Restifo
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amnon ZismanArie S Belldegrun
Feb 28, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Julia I Bárdos, Margaret Ashcroft
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael B AtkinsMatthew L Sherman
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manuelle ViguierLaurent Ferradini
Sep 3, 2004·Nature Reviews. Immunology·Thomas R Malek, Allison L Bayer
Feb 24, 2005·World Journal of Urology·Wolfgang Lilleby, Sophie D Fosså
Mar 10, 2005·International Journal of Cancer. Journal International Du Cancer·Johan W MollingAlfons J M van den Eertwegh
May 4, 2005·Cancer Immunology, Immunotherapy : CII·Subhasis ChattopadhyayBijay Mukherji
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael AtkinsSabina Signoretti
Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tsuyoshi TachibanaMasayuki Imamura
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerBrian I Rini
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giovanni C CesanaHoward L Kaufman
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Robert J MotzerM Dror Michaelson
Jun 20, 2006·Cancer Immunology, Immunotherapy : CII·Chien-Chung Chang, Soldano Ferrone

❮ Previous
Next ❯

Citations

Sep 15, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Bastian SchillingTheresa L Whiteside
Jan 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter A PrietoGiao Q Phan
Mar 14, 2014·Expert Opinion on Biological Therapy·Nancy A Dawson, Erin E Roesch
Apr 27, 2010·Expert Opinion on Biological Therapy·Theresa L Whiteside
Jan 11, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonia BusseUlrich Keilholz
Jan 16, 2010·Annals of the New York Academy of Sciences·Steven KozlowskiRaymond P Donnelly
Jan 16, 2010·Annals of the New York Academy of Sciences·Antonio Romo de Vivar ChavezMichael T Lotze
Mar 25, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Brenda J WingerPolly E Kintzel
Jul 3, 2013·Cancer Control : Journal of the Moffitt Cancer Center·Mayer N Fishman
Oct 16, 2018·Frontiers in Immunology·Claire GorbyIgnacio Moraga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.